Recent Finacing
Recent Raise
Nuclide Therapeutics is a King’s College London spin-out developing ALDH1A1-targeted radiotheranostic drugs to treat therapy-resistant cancers.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Nuclide Therapeutics.
